ISTH 2022 London

The Congress of the International Society on Thrombosis and Haemostasis (ISTH) took place in London from July 9 to 13, 2022.

Dr. Carmen Escuriola Ettingshausen presented our abstract there:

Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Real-life-data documented by eDiary smart medication

The real-life data from smart medication eDiary showed that bleeding episodes decline significantly in patients with hemophilia A after switching from FVIII concentrates to emicizumab.

The follow-up evaluation was presented at the ISTH Congress 2023 in Montréal; the full publication is listed under Publications.

Abstract “Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Real-life-data documented by eDiary smart medication”, presented at the ISTH Congress 2022 in London